Search

everythinglearnresearchcommunity

for

Search:↓

Intralesional triamcinolone injections can effectively stop frontal fibrosing alopecia with minimal side effects.

The supplement with Myo-inositol and D-chiro-inositol improves metabolic symptoms in PCOS, especially when combined with metformin.

Cyclosporine A helps hair grow by blocking a process that would otherwise cause hair cells to die.

Tofacitinib improved hair and nail conditions in a teen with alopecia areata.

Tofacitinib helped an 8-year-old child recover from a type of hair loss that is hard to treat.

The combination treatment showed a higher response rate but no significant survival benefits.

Infliximab can cause SAPHO syndrome, which may improve with Spesolimab and methotrexate.

Stopping azathioprine improved hair loss and bone marrow issues.

IFAP syndrome is a rare genetic disorder causing skin, hair, and eye issues, with limited treatment options.

Mitochondrial Complex I reduces inflammation and increases bone breakdown by affecting certain immune cells.

FMF and mycosis fungoides are variants of the same disease, and bexarotene can be an effective treatment.

ZD1839 (Iressa) causes skin and hair side effects, treatable with tretinoin cream and minocycline.

A woman experienced hair loss, nail changes, bone marrow suppression, and low blood protein after taking azathioprine.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

Finasteride's polymorphic form affects capsule quality and drug effect, requiring strict control.

Early advanced therapies are crucial for better survival in aggressive insulinoma cases.

Diagnosing mycosis fungoides, a rare skin cancer, is difficult in elderly adults and requires careful examination to avoid mistaking it for less serious skin conditions.

Tofacitinib can cause skin eruptions similar to palmoplantar pustulosis.

Cytarabine can cause multiple organ toxicities, especially neurotoxicity, but better research methods are needed to fully understand and predict these effects.

Nurses are crucial in managing chemotherapy side effects for ovarian cancer patients to improve their quality of life.

A woman's hair turned gray and fell out after starting a cancer drug called imatinib mesylate.

Imatinib mesylate can cause skin lightening, especially in Chinese patients, due to its effect on pigment production.

Chemotherapy with carboplatin-paclitaxel causes hair loss in all patients.

Cladribine has known risks and potential new safety concerns, requiring careful monitoring.

Finasteride reduces opioid use and withdrawal symptoms in animals.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

More research is needed to understand chemotherapy-induced hair loss and its phases.

Half of the patients treated with a specific drug for skin cancer experienced hair loss not related to the drug's dosage.